AMT-130 gene therapy reduces Huntington’s disease progression by 75% over three years via a single injection silencing the mutant gene. This breakthrough redefines treatment, inspiring hope while raising cost-accessibility challenges under India’s Rare Disease Policy.
Click to View More
© 2025 iasgyan. All right reserved